- ISIN
- US50540R4092
- CUSIP
- 50540R409
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Mar 29, 1990
Highlights
- Market Cap
- $21.09B
- Enterprise Value
- $28.04B
- EPS (TTM)
- $11.28
- PE Ratio
- 22.56
- Total Revenue (TTM)
- $14.14B
- Gross Profit (TTM)
- $4.01B
- EBITDA (TTM)
- $1.90B
- Year Range
- $241.81 - $293.72
- Target Price
- $308.67
- ROA (TTM)
- 4.93%
- ROE (TTM)
- 10.79%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LH Performance Chart
Laboratory Corporation of America Holdings (LH) is up 2.0% since the beginning of the year. At $254 per share, LH is trading 13.4% below its 52-week high of $294. Investors who bought $1,000 worth of LH shares 5 years ago would now be looking at an investment worth $1,181.
Loading charts...
Returns By Period
Laboratory Corporation of America Holdings (LH) has returned 1.95% so far this year and -1.82% over the past 12 months. Over the last ten years, LH has returned 9.17% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Laboratory Corporation of America Holdings
- 1D
- -0.54%
- 1M
- -1.85%
- YTD
- 1.95%
- 6M
- 0.28%
- 1Y
- -1.82%
- 3Y*
- 9.35%
- 5Y*
- 3.39%
- 10Y*
- 9.17%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
LH Monthly Returns History
Based on dividend-adjusted daily data since Mar 29, 1990, LH's average daily return is +0.06%, while the average monthly return is +1.04%. At this rate, an investment would double in approximately 5.6 years.
Historically, 57% of months were positive and 43% were negative. The best month was Sep 1998 with a return of +44.4%, while the worst month was Aug 1998 at -47.1%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 5 months.
On a daily basis, LH closed higher 48% of trading days. The best single day was Sep 1, 1998 with a return of +27.8%, while the worst single day was Aug 2, 1996 at -35.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.23% | 6.75% | -7.72% | -3.75% | 1.55% | -2.16% | 1.95% | ||||||
| 2025 | 8.93% | 0.78% | -7.29% | 3.55% | 3.60% | 5.44% | -0.93% | 7.16% | 3.26% | -11.53% | 6.12% | -6.66% | 10.62% |
| 2024 | -2.20% | -2.59% | 1.22% | -7.82% | -2.85% | 4.41% | 5.86% | 7.04% | -2.79% | 2.14% | 5.96% | -4.91% | 2.22% |
| 2023 | 7.07% | -4.78% | -4.15% | -1.18% | -5.94% | 13.55% | 3.18% | -2.40% | -3.39% | -0.66% | 8.98% | 4.79% | 13.82% |
| 2022 | -13.64% | -0.04% | -2.80% | -8.87% | 2.98% | -5.01% | 11.87% | -13.84% | -9.08% | 8.32% | 8.81% | -2.17% | -24.41% |
| 2021 | 12.46% | 4.81% | 6.30% | 4.25% | 3.24% | 0.50% | 7.36% | 2.44% | -7.23% | 1.98% | -0.59% | 10.12% | 54.37% |
Benchmark Metrics
Laboratory Corporation of America Holdings has an annualized alpha of 7.21%, beta of 0.71, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since March 29, 1990.
- This stock participated in 56.56% of S&P 500 Index downside but only 55.76% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 7.21%
- Beta
- 0.71
- R²
- 0.11
- Upside Capture
- 55.76%
- Downside Capture
- 56.56%
Return for Risk
Risk / Return Rank
LH ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.11 | ||
| Sortino ratioReturn per unit of downside risk | -2.70 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.37 | -0.36 |
| Calmar ratioReturn relative to maximum drawdown | -0.12 | 2.78 | -2.90 |
| Martin ratioReturn relative to average drawdown | -0.24 | 12.44 | -12.68 |
Dividends
Dividend History
Laboratory Corporation of America Holdings provided a 1.13% dividend yield over the last twelve months, with an annual payout of $2.88 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Dividend | $2.88 | $2.88 | $2.88 | $2.68 | $1.86 |
Dividend yield | 1.13% | 1.15% | 1.26% | 1.18% | 0.92% |
Monthly Dividends
The table displays the monthly dividend distributions for Laboratory Corporation of America Holdings. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $1.44 | ||||||
| 2025 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $2.88 |
| 2024 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $2.88 |
| 2023 | $0.00 | $0.62 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.72 | $0.00 | $0.00 | $0.72 | $0.00 | $2.68 |
| 2022 | $0.62 | $0.00 | $0.00 | $0.62 | $0.00 | $0.00 | $0.62 | $0.00 | $1.86 |
Dividend Yield & Payout
Dividend Yield
Laboratory Corporation of America Holdings has a dividend yield of 1.13%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Laboratory Corporation of America Holdings has a payout ratio of 25.52%, which is quite average when compared to the overall market. This suggests that Laboratory Corporation of America Holdings strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Laboratory Corporation of America Holdings. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Laboratory Corporation of America Holdings was 96.15%, occurring on Aug 31, 1998. Recovery took 2089 trading sessions.
The current Laboratory Corporation of America Holdings drawdown is 11.85%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1998 bear market1998 | -96.15%Aug 1998 | 6y 8mo | 8y 3mo | 14y 11moDec 1991 - Dec 2006 |
COVID crash2020 | -46.58%Mar 2020 | 1mo 4d | 3mo 29d | 5mo 3dFeb 2020 - Jul 2020 |
1991 bear market1991 | -44.70%Jan 1991 | 5mo 18d | 2mo 17d | 8mo 5dJul 1990 - Mar 1991 |
Rate-hike selloffLate 2018 | -36.21%Dec 2018 | 6mo 9d | 1y 1mo | 1y 8moJun 2018 - Feb 2020 |
Bear market2022 | -34.61%Oct 2022 | 9mo 11d | 2y 8mo | 3y 5moJan 2022 - Jun 2025 |
Drawdown Indicators
| LH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.15% | -56.78% | -39.37% |
Max Drawdown (1Y)Largest decline over 1 year | -15.22% | -9.10% | -6.12% |
Max Drawdown (3Y)Largest decline over 3 years | -17.36% | -18.90% | +1.54% |
Max Drawdown (5Y)Largest decline over 5 years | -34.61% | -25.43% | -9.18% |
Max Drawdown (10Y)Largest decline over 10 years | -46.58% | -33.92% | -12.66% |
Current DrawdownCurrent decline from peak | -11.85% | -1.80% | -10.05% |
Average DrawdownAverage peak-to-trough decline | -29.59% | -10.71% | -18.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.62% | 2.03% | +5.59% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Laboratory Corporation of America Holdings over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Laboratory Corporation of America Holdings is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for LH, comparing it with other companies in the Diagnostics & Research industry. Currently, LH has a P/E ratio of 22.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for LH relative to other companies in the Diagnostics & Research industry. Currently, LH has a P/S ratio of 1.5. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for LH in comparison with other companies in the Diagnostics & Research industry. Currently, LH has a P/B value of 2.4. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with LH
Add Laboratory Corporation of America Holdings to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LH